ta101goclin.wordpress.com
Press release | TA101-GOCLIN
https://ta101goclin.wordpress.com/2013/12/23/press-release
Clinical development of TA-101 for the treatment of rheumatoid arthritis. December 23, 2013. The Press Release of TA101 GOCLIN project was disseminated today to the local press. The document can be downloaded here. December 23, 2013. Consortium meeting in Lisbon. Kick-off meeting in Brussels. Know more about the partners of this consortium. Learn about the workplan. The project in a nutshell. TA101 GOCLIN Project is launched. Kick-off meeting in Brussels. Consortium meeting in Lisbon →.
ta101goclin.wordpress.com
Kick-off meeting in Brussels | TA101-GOCLIN
https://ta101goclin.wordpress.com/2013/10/21/keek-off-meeting-in-brussels
Clinical development of TA-101 for the treatment of rheumatoid arthritis. Kick-off meeting in Brussels. October 21, 2013. The project’s kick-off meeting was held in Brussels on the 29th of October. October 21, 2013. Consortium meeting in Lisbon. Learn about the workplan. TA101 GOCLIN Project is launched. Know more about the partners of this consortium. Press release →. SGS LIFE SCIENCE SERVICES. Blog at WordPress.com.
q-biologicals.com
Capabilities | Q-Biological, Quality you can rely on ›› Speed-up the development and manufacturing of your biologicals ›› Gent, Belgium
http://www.q-biologicals.com/capabilities
All our activities are carried out under the ISO9001 Quality regime, including the cGMP manufacturing. We have been certified by Lloyds, click here. To see our certificate. BioIncubator Technologiepark 4 B-9052 Zwijnaarde, Belgium. Tel : 32 (0)9 241 11 04 info@q-biologicals.be.
q-biologicals.com
News & Events | Q-Biological, Quality you can rely on ›› Speed-up the development and manufacturing of your biologicals ›› Gent, Belgium
http://www.q-biologicals.com/news-events
Opening of our GMP facility. Posted on February 01, 2015. Hosted by by Philippe Muyters, Flemish Minister for Work, Economy, Innovation and Sports. SEPS Pharma, AmatsiQBiologicals and VIB invite you to the official opening of our GMP facility by Philippe Muyters, Flemish Minister for Work, Economy, Innovation and Sports. The combination of our expertise and this GMP infrastructure is unique for the Flemish biotech sector. BioIncubator Technologiepark 4 B-9052 Zwijnaarde, Belgium.
ta101goclin.wordpress.com
The project in a nutshell | TA101-GOCLIN
https://ta101goclin.wordpress.com/2013/10/02/the-project-in-a-nutshell
Clinical development of TA-101 for the treatment of rheumatoid arthritis. The project in a nutshell. October 2, 2013. Get an overview of the project here. October 2, 2013. Know more about the partners of this consortium. TA101 GOCLIN Project is launched. TA101 GOCLIN Project is launched. Learn about the workplan →. SGS LIFE SCIENCE SERVICES. Blog at WordPress.com.
ta101goclin.wordpress.com
October | 2013 | TA101-GOCLIN
https://ta101goclin.wordpress.com/2013/10
Clinical development of TA-101 for the treatment of rheumatoid arthritis. Monthly Archives: October 2013. Kick-off meeting in Brussels. The project’s kick-off meeting was held in Brussels on the 29th of October. October 21, 2013. Know more about the partners of this consortium. Learn more about the partners of the TA101 GOCLIN project – click here,. October 4, 2013. Learn about the workplan. Learn more about the project’s workplan -click here. October 3, 2013. The project in a nutshell. October 2, 2013.
kreskado.be
Testimonials
http://www.kreskado.be/testimonials
Set up a web shop. Data Protection Best Practices. It would have been very helpful to have had this Q&A when setting up Q-Biologicals.". Annie Van Broekhoven, CEO Q-Biologicals. Vanessa Vankerckhoven, PhD, CEO Novosanis. Patricia Ceyssens, Co-Founder at WeWatt.
ta101goclin.wordpress.com
Working packages | TA101-GOCLIN
https://ta101goclin.wordpress.com/working-packages
Clinical development of TA-101 for the treatment of rheumatoid arthritis. The project’s workplan can be illustrated as follows:. WP1 – Process development of TA101 in cGMP conditions. The production process for TA101 in conditions for delivery into humans will be optimized. The process will determine the best host system for the production of TA101 and will also determine the optimized process for purification of TA101. WP2 – Clinical research of Phase I. WP3 – Development of a medical device for t...